Malignant epithelioid mesothelioma

MONDO:0005599

A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.

Also known as: epithelial mesothelioma, epithelioid mesothelioma, epithelioid mesothelioma, malignant, epithelioid mesothelioma, malignant (morphologic abnormality), malignant epithelial mesothelioma

2741 clinical trials for this condition and its sub-types, 5 tagged with Malignant epithelioid mesothelioma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Malignant mesothelioma (108)

Sub-types of Malignant epithelioid mesothelioma

Pleural epithelioid mesothelioma 8 trials

Including sub-types (2741) Tagged with Malignant epithelioid mesothelioma (5)

Trials to join now! 2 Not yet finished but already full! 2 Completed 1

Immune booster shows promise against rare cancer

Disease control Completed

This study tested a drug called pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could shrink tumors or slow the disease, but…

Phase 2 • Sponsor: University of Chicago • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC

Malignant epithelioid mesothelioma

Where it sits in the disease tree

Immune booster shows promise against rare cancer